Cargando…
Targeted Delivery of Mesenchymal Stem Cell-Derived Nanovesicles for Spinal Cord Injury Treatment
Due to the safety issues and poor engraftment of mesenchymal stem cell (MSC) implantation, MSC-derived exosomes have been spotlighted as an alternative therapy for spinal cord injury (SCI). However, insufficient productivity of exosomes limits their therapeutic potential for clinical application. Mo...
Autores principales: | Lee, Ju-Ro, Kyung, Jae Won, Kumar, Hemant, Kwon, Sung Pil, Song, Seuk Young, Han, In-Bo, Kim, Byung-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312698/ https://www.ncbi.nlm.nih.gov/pubmed/32545361 http://dx.doi.org/10.3390/ijms21114185 |
Ejemplares similares
-
Nanovesicles derived from iron oxide nanoparticles–incorporated mesenchymal stem cells for cardiac repair
por: Lee, Ju-Ro, et al.
Publicado: (2020) -
Umbilical Cord Mesenchymal Stem Cell-Derived Nanovesicles Potentiate the Bone-Formation Efficacy of Bone Morphogenetic Protein 2
por: Lim, Songhyun, et al.
Publicado: (2020) -
Recent advances in lipid nanovesicles for targeted treatment of spinal cord injury
por: Lu, Di, et al.
Publicado: (2023) -
Senescent cancer cell-derived nanovesicle as a personalized therapeutic cancer vaccine
por: Hong, Jihye, et al.
Publicado: (2023) -
Sodium alginate and naloxone loaded macrophage-derived nanovesicles for the treatment of spinal cord injury
por: Liu, Xiaoyao, et al.
Publicado: (2022)